Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

End-of-day quote. End-of-day quote  - 02/09
76.4 USD   +12.60%
12:13a RITE AID, WALGR : Report
01/20 FTC NOT SOLD ON : Bloomberg
01/20 WALGREENS BOOTS : to pay $50 mln to resolve US prescription kickback..
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 02:39pm CET

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
12:13a RITE AID, WALGREENS MERGER PLAN HASN : Report
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/20 WALGREENS BOOTS ALLIANCE : to pay $50 mln to resolve US prescription kickback ca..
01/19 WALGREENS : Flu Index™ for Week of Jan. 15, 2017
01/18 WALGREENS BOOTS ALLIANCE : to Webcast Annual Meeting of Stockholders
01/18 WALGREENS BOOTS ALLIANCE : Makes Life Saving Naloxone Available Without Prescrip..
01/13 WALGREENS BOOTS ALLIANCE : Flu Index for Week of Jan. 8, 2017; Brownsville, Texa..
01/12 WALGREENS : Flu Index™ for Week of Jan. 8, 2017
01/12 WALGREENS BOOTS ALLIANCE : Florida Hospital and Walgreens Announce Retail Health..
01/11 Walgreens and FedEx Team Up to Offer FedEx Drop Off and Pick Up at Thousands ..
More news
Sector news : Drug Retailers - NEC
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 120 229 M
EBIT 2017 7 394 M
Net income 2017 4 914 M
Debt 2017 7 425 M
Yield 2017 1,84%
P/E ratio 2017 17,95
P/E ratio 2018 15,90
EV / Sales 2017 0,80x
EV / Sales 2018 0,75x
Capitalization 88 209 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 94,4 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%88 209
WALGREENS BOOTS ALLIAN..-1.26%88 209
CVS HEALTH CORP3.36%86 979
EXPRESS SCRIPTS HOLDIN..4.30%44 243
MCKESSON CORPORATION7.00%33 976
CARDINAL HEALTH INC4.25%24 014
More Results